Back to search

Article

ACE2 expression in PBMC and plasma markers of vasculopathy and fibrosis during early COVID – implications for post-COVID conditions

2023-10-05

Abstract excerpt

<h4>Background: </h4> Severe COVID is uncommon, restricted to 19% of the population. In response to the first virus wave (alpha variant of SARS-CoV-2), we investigated whether variable expression of angiotensin converting enzyme 2 (ACE2) in blood might identify this difference in risk. <h4>Methods: </h4> The study was IRB-approved, comparing patients hospitalized with severe COVID to healthy controls. A single bl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
40eb9bb1-2ae6-5aab-aae3-8e96f1485c5b
DOI
10.21203/rs.3.rs-3374090/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ACE2 expression in PBMC and plasma markers of vasculopathy and fibrosis during early COVID – implications for post-COVID conditionsDOI 10.21203/rs.3.rs-3374090/v1
Select a neighboring publication to make it the new centre.